|
Dr. A V Rama Rao - Founder, Chairman and Managing Director
|
|
|
|
|
 |
Recognized institutional builder and respected scientist with over 35 years experience in research and leadership. Former director of the Indian Institute of Chemical Technology (IICT) - managing over 1,400 employees including 500 scientists |
|
|
His work on the isolation, structure elucidation of natural products and the syntheses of complex natural products is described in 262 research papers & 30 patents |
|
|
Developed more than 50 drug technologies that have been commercialized by the pharmaceutical industry |
|
|
Bestowed with the title of "Padmashree" by the President of India in 1991 |
|
|
Currently leads the company in the position of Chairman |
|
|
Has been involved with the International Policy making Organizations including: |
|
|
|
Member, Scientific & Technical Advisory Committee of the UNDP/World Bank/WHO special program for research and training in tropical diseases (1992-95); |
|
|
|
Titular member of IUPAC Sectional Committee, Medicinal Chemistry Division (1988-91); |
|
|
|
Member, Technical Advisory Committee on CFC Destruction Technologies of the United Nations Environmental Protection Agency; |
|
|
|
Fellow of the Indian National Science Academy and Third World Academy of Sciences |
|
|
|
|
|
|
|
|
|
|
|
|
Dr. Chandra Ramarao - Director, Research and Operations
|
|
|
|
|
|
Joined Avra Laboratories in 2003 and heads the research and business development activities of the company |
|
|
Dr. Chandra completed his PhD from Cambridge University in 1999 under the supervision of Prof Ian Fleming and developed a method to induce 1,5 stereo-centers in open-chain (acyclic) systems. He continued in Cambridge as a post-doc working in Prof S V Ley’s group until 2002 |
|
|
During his time in Prof. Ley’s group, Dr. Chandra worked closely with several multinational companies including Astra Zeneca, Syngenta and Avecia |
|
|
His past work encompasses stereo-controlled synthesis, nano-particulate transition-metal catalysis, development of micro-encapsulation techniques, development of solid-supported reagents and use of ionic liquids and super critical carbon dioxide as alternative solvents |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mr. R Ramakrishna - Executive Director
|
|
|
|
|
|
Mr. Ramakrishna’s expertise lies in the design and early stage planning of projects and infrastructure development along with strategic sourcing of raw materials |
|
|
Responsible for implementing Avra's quality policies and systems based on cGMP guidelines and establishing Avra’s state-of-the-art dedicated pilot plant and Class -100,000 fully contained Steroid plant |
|
|
His scientific interests include the design and development of non infringing patentable routes for the synthesis of various APIs in a cost effective manner with minimal impact to the environment |
|
|
Formal education includes a Master of Science (M.Sc. Industrial Chemistry) and a Master of Business Administration (MBA) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mr. T. K. Sunderaswaran - General Manager, Business Development |
|
|
|
|
|
Mr Sunderaswaran has a degree in Chemical Engineering from AC Tech, Chennai and PGDM from IIM-Bangalore |
|
|
He has over 25 years of experience in the fine chemical business |
|
|
Established the Lancaster brand of research chemical in India. |
|
|
He built the business from scratch and ensured a growth of 50 fold over a period of 7 years |
|
|
|
Currently handles all facets of operations of Avra Synthesis along with business development activities of Avra Laboratories |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
